Abstract
Staphylococcus aureus (S. aureus) is a common pathogenic bacterium that causes various diseases in both humans and animals. With the increased prevalence of methicillin-resistant S. aureus, the therapeutic effects of commonly used antibiotics are limited against S. aureus infection. Novel treatment strategies and new antibiotics are needed urgently to address this concern. Many studies have shown that virulence factors secreted from S. aureus play vital roles in their pathogenic processes. Alpha-hemolysin (Hla), an important exotoxin in S. aureus, is one such virulence factor that increases sensitivity of multiple host cells to S. aureus resulting in various diseases. Eriodictyol is a flavonoid compound that exists in many fruits and vegetables. In this study, eriodictyol was demonstrated to inhibit the expression of Hla by hemolysis assays, western blotting, and RT-qPCR at the sub-minimal inhibitory concentration. In live/dead and cytotoxicity assays, the results showed that eriodictyol protected A549 cells against Hla-induced injury in a dose-dependent manner. The minimal inhibitory concentration of eriodictyol against S. aureus was 512 µg/mL. Eriodictyol can downregulate S. aureus Hla at both the expressional and transcriptional levels without affecting S. aureus growth. In addition, cell assays had proved that eriodictyol could protect A549 cells against Hla damage. Eriodictyol could therefore have the potential to treat S. aureus infection targeting Hla.
Similar content being viewed by others
References
Allen RC, Popat R, Diggle SP, Brown SP (2014) Targeting virulence: can we make evolution-proof drugs? Nat Rev Microbiol 12:300–308
Antonanzas F, Lozano C, Torres C (2015) Economic features of antibiotic resistance: the case of methicillin-resistant Staphylococcus aureus. Pharmacoeconomics 33:285–325
Barber M (1961) Methicillin-resistant staphylococci. J Clin Pathol 14:385–393
Berube BJ, Juliane BW (2013) Staphylococcus aureus α-Toxin: nearly a century of intrigue. Toxins 5:1140–1166
Cohen TS, Hilliard JJ, Jones-Nelson O, Keller AE, O’Day T, Tkaczyk C et al (2016) Staphylococcus aureus α toxin potentiates opportunistic bacterial lung infections. Sci Transl Med 8:329ra331
Fossum Moen AE, Tannaes TM, Leegaard TM (2013) USA300 methicillin-resistant Staphylococcus aureus in Norway. APMIS 121:1091–1096
Hiramatsu K, Katayama Y, Matsuo M, Sasaki T, Morimoto Y, Sekiguchi A, Baba T (2014) Multi-drug-resistant Staphylococcus aureus and future chemotherapy. J Infect Chemother 20:593–601
Hongen L, Xiaoran Z, Jianfeng W, Yu D, Song M, Rui L et al (2015) β-sitosterol interacts with pneumolysin to prevent Streptococcus pneumoniae infection. Sci Rep UK 5:17668
Joost H, Toraño PG, Fidel E, Klaassen CH, Menéndez VD, Meis JF, Andreas V (2012) USA300 methicillin-resistant Staphylococcus aureus in Cuba. Antimicrob Resist Infect Control 1:1–2
Kati S, Nadja L, Miguel PM, Alexandra F, Gabriela S, Anne HB et al (2014) USA300 methicillin-resistant Staphylococcus aureus in Zurich, Switzerland between 2001 and 2013. Int J Med Microbiol 304:1118–1122
Lee ER, Kim JH, Kang YJ, Cho SG (2007) The anti-apoptotic and anti-oxidant effect of eriodictyol on UV-induced apoptosis in keratinocytes. Biol Pharm Bull 30:32–37
Li H et al (2016) Inhibition of sortase A by chalcone prevents Listeria monocytogenes infection. Biochem Pharmacol 106:19–29
Liu K, Chen Y, Zhang B, Niu X, Song M, Luo Z et al (2011) Eriodictyol inhibits RSK2-ATF1 signaling and suppresses EGF-induced neoplastic cell transformation. J Biol Chem 286:2057–2066
Lowy FD (1998) Staphylococcus aureus infections. N Engl J Med 339:520–532
Macheboeuf P, Contreras-Martel C, Job V, Dideberg O, Dessen A (2006) Penicillin binding proteins: key players in bacterial cell cycle and drug resistance processes. FEMS Microbiol Rev 30:673–691
Mandalari G et al (2007) Antimicrobial activity of flavonoids extracted from bergamot (Citrus bergamia Risso) peel, a byproduct of the essential oil industry. J Appl Microbiol 103:2056–2064
Mangold M et al (1993) Synthesis of group A streptococcal virulence factors is controlled by a regulatory RNA molecule. EMBO J 12:3967–3975
Meemarquet NLVD. (2016) Whole-genome sequencing analysis: an essential tool for shedding light on the obscure evolution of Staphylococcus aureus USA300. J Infect Dis 213:1362–1363
Mokdadbzeouich I, Mustapha N, Sassi A, Bedoui A, Ghoul M, Ghedira K, Chekirghedira L (2016) Investigation of immunomodulatory and anti-inflammatory effects of eriodictyol through its cellular anti-oxidant activity. Cell Stress Chaperon 21:1–9
Monforte MT, Fimiani V, Lanuzza F, Naccari C, Restuccia S, Galati EM (2014) Feijoa sellowiana Berg fruit juice: anti-inflammatory effect and activity on superoxide anion generation. J Med Food 17:455–461
Montgomery CP, Boyle-Vavra S, Adem PV, Lee JC, Husain AN, Clasen J, Daum RS (2008) Comparison of Virulence in community-associated methicillin-resistant Staphylococcus aureus pulsotypes USA300 and USA400 in a rat model of pneumonia. J Infect Dis 198:561–570
Montgomery CP, Boyle-Vavra S, Daum RS (2010) Importance of the global regulators Agr and SaeRS in the pathogenesis of CA-MRSA USA300 infection. PLoS ONE 5:e15177
Morfeldt E, Taylor D, Von GA, Arvidson S (1995) Activation of alpha-toxin translation in Staphylococcus aureus by the trans-encoded antisense RNA, RNAIII. EMBO J 14:4569–4577
Nimmo GR (2012) USA300 abroad: global spread of a virulent strain of community-associated methicillin-resistant Staphylococcus aureus. Clin Microbiol Infect 18:725–734
Ohlsen K, Ziebuhr W, Koller KP, Hell W, Wichelhaus TA, Hacker J (1998) Effects of subinhibitory concentrations of antibiotics on alpha-toxin (hla) gene expression of methicillin-sensitive and methicillin-resistant Staphylococcus aureus isolates. Antimicrob Agents Chemotherp 42:2817–2823
Powel KE, Garcia MC, Lynne AM (2012) Selective pressure potential of antimicrobial agents to facilitate spread of resistance plasmid. Nova Publishing Inc., New York
Qiu J, Niu X, Dong J, Wang D, Wang J, Li H et al (2012) Baicalin protects mice from Staphylococcus aureus pneumonia via inhibition of the cytolytic activity of α-hemolysin. J Infect Dis 206:292–301
Rao Q, Shang W, Hu X, Rao X (2015) Staphylococcus aureus ST121: a globally disseminated hypervirulent clone. J Med Microbiol 64:1462–1473
Rasko DA, Sperandio V (2010) Anti-virulence strategies to combat bacteria-mediated disease. Nat Rev Drug Discov 9:117–128
Recsei P, Kreiswirth B, O’Reilly M, Schlievert P, Gruss A, Novick RP (1986) Regulation of exoprotein gene expression in Staphylococcus aureus by agar. Mol Gen Genet 202:58–61
Vasudevan P, Nair MK, Annamalai T, Venkitanarayanan KS (2003) Phenotypic and genotypic characterization of bovine mastitis isolates of Staphylococcus aureus for biofilm formation. Vet Microbiol 92:179–185
Vojtov N, Ross HF, Novick RP (2002) Global repression of exotoxin synthesis by Staphylococcal superantigens. Proc Natl Acad Sci USA 99:10102–10107
Wang X, Shi H, Zhang L, Li X (2009) A new Chalcone Glycoside, a new Tetrahydrofuranoid Lignan, and antioxidative constituents from the stems and leaves of Viburnum propinquum. Planta Med 75(11):1262–1265
Wang J, Qiu J, Tan W, Zhang Y, Wang H, Zhou X et al (2015) Fisetin inhibits Listeria monocytogenes virulence by interfering with the oligomerization of Listeriolysin O. J Infect Dis 211:1376–1387
Zhu G, Guo H, Huang Y, Chunting WU, Zhang X (2015) Eriodictyol, a plant flavonoid, attenuates LPS-induced acute lung injury through its antioxidative and anti-inflammatory activity. Chest 10:2259–2266
Acknowledgements
The study was funded by General Project of Sichuan Provincial Department of Education (Grant No. 16ZB0036) and National Natural Science Foundation of China (Grant No. 31702284).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interest.
Ethical approval
The defibrinated rabbit blood was purchased from Zheng Zhou Jiu Long Biological Products Co Ltd and no animals were directly used in the experiments above.
Rights and permissions
About this article
Cite this article
Xuewen, H., Ping, O., Zhongwei, Y. et al. Eriodictyol protects against Staphylococcus aureus-induced lung cell injury by inhibiting alpha-hemolysin expression. World J Microbiol Biotechnol 34, 64 (2018). https://doi.org/10.1007/s11274-018-2446-3
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11274-018-2446-3